Cargando…
Inorganic Nanovehicle Targets Tumor in an Orthotopic Breast Cancer Model
The clinical efficacy of conventional chemotherapeutic agent, methotrexate (MTX), can be limited by its very short plasma half-life, the drug resistance, and the high dosage required for cancer cell suppression. In this study, a new drug delivery system is proposed to overcome such limitations. To r...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961742/ https://www.ncbi.nlm.nih.gov/pubmed/24651154 http://dx.doi.org/10.1038/srep04430 |